SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 741.65 |
| Enterprise Value ($M) | -70.63 |
| Book Value ($M) | 1,131.31 |
| Book Value / Share | 2.96 |
| Price / Book | 0.66 |
| NCAV ($M) | 906.35 |
| NCAV / Share | 2.37 |
| Price / NCAV | 0.82 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.04 |
| Return on Assets (ROA) | -0.04 |
| Return on Equity (ROE) | -0.04 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 23.05 |
| Current Ratio | 24.24 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 959.17 |
| Assets | 1,184.13 |
| Liabilities | 52.82 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Altria Group, Inc. | 41.00 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 267,405 | 1,019,261 | 26.24 | |
| 240,433 | 779,355 | 30.85 | |
| 362,976 | 1,190,128 | 30.50 | |
| 417,629 | 1,279,098 | 32.65 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CLYM – Climb Bio, Inc. | CMRX – Chimerix, Inc. |
| CRMD – CorMedix Inc. | CRSP – CRISPR Therapeutics AG |
| CRVS – Corvus Pharmaceuticals, Inc. |